TX
Texas Senate Bill SB199

Texas 2015 - 84th Regular

Texas Senate Bill SB199 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11 84R1124 JSC-D
22 By: Perry S.B. No. 199
33
44
55 A BILL TO BE ENTITLED
66 AN ACT
77 relating to the designation of certain synthetic compounds to
88 Penalty Group 2 or 2-A of the Texas Controlled Substances Act.
99 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
1010 SECTION 1. Sections 481.002(5) and (6), Health and Safety
1111 Code, are amended to read as follows:
1212 (5) "Controlled substance" means a substance,
1313 including a drug, an adulterant, and a dilutant, listed in
1414 Schedules I through V or Penalty Group [Groups] 1, 1-A, [or] 2, 2-A,
1515 3, or [through] 4. The term includes the aggregate weight of any
1616 mixture, solution, or other substance containing a controlled
1717 substance.
1818 (6) "Controlled substance analogue" means:
1919 (A) a substance with a chemical structure
2020 substantially similar to the chemical structure of a controlled
2121 substance in Schedule I or II or Penalty Group 1, 1-A, [or] 2, or
2222 2-A; or
2323 (B) a substance specifically designed to produce
2424 an effect substantially similar to, or greater than, the effect of a
2525 controlled substance in Schedule I or II or Penalty Group 1, 1-A,
2626 [or] 2, or 2-A.
2727 SECTION 2. Section 481.103(a), Health and Safety Code, is
2828 amended to read as follows:
2929 (a) Penalty Group 2 consists of:
3030 (1) any quantity of the following hallucinogenic
3131 substances, their salts, isomers, and salts of isomers, unless
3232 specifically excepted, if the existence of these salts, isomers,
3333 and salts of isomers is possible within the specific chemical
3434 designation:
3535 alpha-ethyltryptamine;
3636 alpha-methyltryptamine;
3737 5-(2-aminopropyl)benzofuran (5-APB);
3838 6-(2-aminopropyl)benzofuran (6-APB);
3939 5-(2-aminopropyl)-2,3-dihydrobenzofuran
4040 (5-APDB);
4141 6-(2-aminopropyl)-2,3-dihydrobenzofuran
4242 (6-APDB);
4343 5-(2-aminopropyl)indole (Trade or other names:
4444 5-IT, 5-API);
4545 6-(2-aminopropyl)indole (Trade or other names:
4646 6-IT, 6-API);
4747 Benzothiophenylcyclohexylpiperidine (BTCP);
4848 4-bromo-2, 5-dimethoxyamphetamine (some trade or
4949 other names: 4-bromo-2, 5-dimethoxy-alpha-methylphenethylamine;
5050 4-bromo-2, 5-DMA);
5151 4-bromo-2, 5-dimethoxyphenethylamine;
5252 8-bromo-alpha-methyl-benzo[1,2-b:4,5-b']difuran-
5353 4-ethanamine (Trade or other name: Bromo-DragonFLY);
5454 Bufotenine (some trade and other names: 3-(beta-
5555 Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)- 5-
5656 indolol; N, N-dimethylserotonin; 5-hydroxy-N, N-
5757 dimethyltryptamine; mappine);
5858 Desoxypipradrol (2-benzhydrylpiperidine);
5959 Diethyltryptamine (some trade and other names: N,
6060 N-Diethyltryptamine, DET);
6161 2, 5-dimethoxyamphetamine (some trade or other
6262 names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA);
6363 2, 5-dimethoxy-4-ethylamphetamine (trade or other
6464 name: DOET);
6565 2, 5-dimethoxy-4-(n)-propylthiophenethylamine
6666 (trade or other name: 2C-T-7);
6767 Dimethyltryptamine (trade or other name: DMT);
6868 Diphenylprolinol (diphenyl(pyrrolidin-2-yl)
6969 methanol, D2PM);
7070 Dronabinol (synthetic) in sesame oil and
7171 encapsulated in a soft gelatin capsule in a U.S. Food and Drug
7272 Administration approved drug product (some trade or other names for
7373 Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9-
7474 trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9-
7575 (trans)- tetrahydrocannabinol);
7676 Ethylamine Analog of Phencyclidine (some trade or
7777 other names: N-ethyl-1-phenylcyclohexylamine, (1-
7878 phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine,
7979 cyclohexamine, PCE);
8080 2-ethylamino-2-(3-methoxyphenyl)cyclohexanone
8181 (Trade or other name: methoxetamine);
8282 Ibogaine (some trade or other names: 7-Ethyl-6,
8383 6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-
8484 pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.);
8585 5-iodo-2-aminoindane (5-IAI);
8686 Mescaline;
8787 5-methoxy-N, N-diisopropyltryptamine
8888 (5-MeO-DIPT);
8989 5-methoxy-N, N-diallyltryptamine (5MeO-DALT);
9090 5-methoxy-3, 4-methylenedioxy amphetamine;
9191 4-methoxyamphetamine (some trade or other names:
9292 4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine;
9393 PMA);
9494 4-methoxymethamphetamine (PMMA);
9595 2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone
9696 (Trade or other names: 2-MeO-ketamine; methoxyketamine);
9797 1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP,
9898 PPMP);
9999 4-methyl-2, 5-dimethoxyamphetamine (some trade
100100 and other names: 4-methyl-2, 5-dimethoxy-alpha-
101101 methylphenethylamine; "DOM"; "STP");
102102 3,4-methylenedioxy methamphetamine (MDMA, MDM);
103103 3,4-methylenedioxy amphetamine;
104104 3,4-methylenedioxy N-ethylamphetamine (Also
105105 known as N-ethyl MDA);
106106 5,6-methylenedioxy-2-aminoindane (MDAI);
107107 Nabilone (Another name for nabilone: (+)-trans-
108108 3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6,
109109 6-dimethyl-9H-dibenzo[b,d] pyran-9-one;
110110 N-benzylpiperazine (some trade or other names:
111111 BZP; 1-benzylpiperazine);
112112 N-ethyl-3-piperidyl benzilate;
113113 N-hydroxy-3,4-methylenedioxyamphetamine (Also
114114 known as N-hydroxy MDA);
115115 4-methylaminorex;
116116 N-methyl-3-piperidyl benzilate;
117117 O-Acetylpsilocin (Trade or other name:
118118 4-Aco-DMT);
119119 Parahexyl (some trade or other names: 3-Hexyl-1-
120120 hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d]
121121 pyran; Synhexyl);
122122 1-Phenylcyclohexylamine;
123123 1-Piperidinocyclohexanecarbonitrile (PCC);
124124 Psilocin;
125125 Psilocybin;
126126 Pyrrolidine Analog of Phencyclidine (some trade
127127 or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP);
128128 Tetrahydrocannabinols, other than marihuana, and
129129 synthetic equivalents of the substances contained in the plant, or
130130 in the resinous extractives of Cannabis, or synthetic substances,
131131 derivatives, and their isomers with similar chemical structure and
132132 pharmacological activity such as:
133133 delta-1 cis or trans tetrahydrocannabinol,
134134 and their optical isomers;
135135 delta-6 cis or trans tetrahydrocannabinol,
136136 and their optical isomers;
137137 delta-3, 4 cis or trans
138138 tetrahydrocannabinol, and its optical isomers;
139139 compounds of these structures, regardless of
140140 numerical designation of atomic positions, since nomenclature of
141141 these substances is not internationally standardized;
142142 Thiophene Analog of Phencyclidine (some trade or
143143 other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl
144144 Analog of Phencyclidine; TPCP, TCP);
145145 1-pyrrolidine (some trade or other name: TCPy);
146146 1-(3-trifluoromethylphenyl)piperazine (trade or
147147 other name: TFMPP); and
148148 3,4,5-trimethoxy amphetamine;
149149 (2) Phenylacetone (some trade or other names:
150150 Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl
151151 ketone);
152152 (3) unless specifically excepted or unless listed in
153153 another Penalty Group, a material, compound, mixture, or
154154 preparation that contains any quantity of the following substances
155155 having a potential for abuse associated with a depressant or
156156 stimulant effect on the central nervous system:
157157 Aminorex (some trade or other names: aminoxaphen;
158158 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5-
159159 phenyl-2-oxazolamine);
160160 Amphetamine, its salts, optical isomers, and
161161 salts of optical isomers;
162162 Cathinone (some trade or other names: 2-amino-1-
163163 phenyl-1-propanone, alpha-aminopropiophenone, 2-
164164 aminopropiophenone);
165165 Etaqualone and its salts;
166166 Etorphine Hydrochloride;
167167 Fenethylline and its salts;
168168 Lisdexamfetamine, including its salts, isomers,
169169 and salts of isomers;
170170 Mecloqualone and its salts;
171171 Methaqualone and its salts;
172172 Methcathinone (some trade or other names: 2-
173173 methylamino-propiophenone; alpha-(methylamino)propriophenone;
174174 2-(methylamino)-1-phenylpropan-1-one; alpha-N-
175175 methylaminopropriophenone; monomethylpropion; ephedrone, N-
176176 methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR
177177 1431);
178178 N-Ethylamphetamine, its salts, optical isomers,
179179 and salts of optical isomers; and
180180 N,N-dimethylamphetamine (some trade or other
181181 names: N,N,alpha-trimethylbenzeneethaneamine;
182182 N,N,alpha-trimethylphenethylamine), its salts, optical isomers,
183183 and salts of optical isomers; and
184184 (4) any compound structurally derived from
185185 2-aminopropanal by substitution at the 1-position with any
186186 monocyclic or fused-polycyclic ring system, including:
187187 (A) compounds further modified by:
188188 (i) substitution in the ring system to any
189189 extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl,
190190 hydroxyl, or halide substituents), whether or not further
191191 substituted in the ring system by other substituents;
192192 (ii) substitution at the 3-position with an
193193 acyclic alkyl substituent; or
194194 (iii) substitution at the 2-amino nitrogen
195195 atom with alkyl, [or] dialkyl, benzyl, or methoxybenzyl groups, or
196196 inclusion of the 2-amino nitrogen atom in a cyclic structure; and
197197 (B) by example, compounds such as:
198198 4-Methoxymethcathinone (Also known as
199199 Methedrone);
200200 4-Methylmethcathinone (Also known as
201201 Mephedrone);
202202 3,4-Dimethylmethcathinone (Also known as
203203 3,4-DMMC);
204204 3-Fluoromethcathinone (Also known as 3-FMC);
205205 4-Fluoromethcathinone (Also known as
206206 Flephedrone);
207207 3,4-Methylenedioxy-N-methylcathinone (Also
208208 known as Methylone);
209209 3,4-Methylenedioxypyrovalerone (Also known
210210 as MDPV);
211211 alpha-Pyrrolidinopentiophenone (Also known
212212 as alpha-PVP);
213213 Naphthylpyrovalerone (Also known as
214214 Naphyrone);
215215 beta-Keto-N-methylbenzodioxolylpropylamine
216216 (Also known as Butylone);
217217 beta-Keto-N-methylbenzodioxolylpentanamine
218218 (Also known as Pentylone);
219219 beta-Keto-Ethylbenzodioxolylbutanamine
220220 (Also known as Eutylone); and
221221 3,4-methylenedioxy-N-ethylcathinone (Also
222222 known as Ethylone).
223223 SECTION 3. Section 481.1031, Health and Safety Code, is
224224 amended to read as follows:
225225 Sec. 481.1031. PENALTY GROUP 2-A. Penalty Group 2-A
226226 consists of any quantity of a synthetic chemical compound that is a
227227 cannabinoid receptor agonist and mimics the pharmacological effect
228228 of naturally occurring cannabinoids, including:
229229 naphthoylindoles structurally derived from
230230 3-(1-naphthoyl)indole with or without [by] substitution at the
231231 nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl,
232232 cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)
233233 methyl, cyanoalkyl, (N-methylpyrrolidin-2-yl)methyl,
234234 (tetrahydropyran-4-yl)methyl, ((N-methyl)-3-morpholinyl)methyl,
235235 or 2-(4-morpholinyl)ethyl, whether or not further substituted in
236236 the indole ring to any extent, whether or not substituted in the
237237 napthyl ring to any extent, including:
238238 AM-2201;
239239 JWH-004;
240240 JWH-007;
241241 JWH-009;
242242 JWH-015;
243243 JWH-016;
244244 JWH-018;
245245 JWH-019;
246246 JWH-020;
247247 JWH-046;
248248 JWH-047;
249249 JWH-048;
250250 JWH-049;
251251 JWH-050;
252252 JWH-073;
253253 JWH-076;
254254 JWH-079;
255255 JWH-080;
256256 JWH-081;
257257 JWH-082;
258258 JWH-083;
259259 JWH-093;
260260 JWH-094;
261261 JWH-095;
262262 JWH-096;
263263 JWH-097;
264264 JWH-098;
265265 JWH-099;
266266 JWH-100;
267267 JWH-116;
268268 JWH-122;
269269 JWH-148;
270270 JWH-149;
271271 JWH-153;
272272 JWH-159;
273273 JWH-164;
274274 JWH-165;
275275 JWH-166;
276276 JWH-180;
277277 JWH-181;
278278 JWH-182;
279279 JWH-189;
280280 JWH-193;
281281 JWH-198;
282282 JWH-200;
283283 JWH-210;
284284 JWH-211;
285285 JWH-212;
286286 JWH-213;
287287 JWH-234;
288288 JWH-235;
289289 JWH-239;
290290 JWH-240;
291291 JWH-241;
292292 JWH-242;
293293 JWH-258;
294294 JWH-259;
295295 JWH-260;
296296 JWH-262;
297297 JWH-267;
298298 JWH-386;
299299 JWH-387;
300300 JWH-394;
301301 JWH-395;
302302 JWH-397;
303303 JWH-398;
304304 JWH-399;
305305 JWH-400;
306306 JWH-412;
307307 JWH-413; and
308308 JWH-414;
309309 naphthylmethylindones structurally derived from
310310 1H-indol-3-yl-(1-naphthyl)methane with or without [by]
311311 substitution at the nitrogen atom of the indole ring by alkyl,
312312 haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
313313 (N-methylpiperidin-2-yl)methyl, cyanoalkyl, (N-methylpyrrolidin-
314314 2-yl)methyl, (tetrahydropyran-4-yl)methyl, ((N-methyl)-3-
315315 morpholinyl)methyl, or 2-(4-morpholinyl)ethyl, whether or not
316316 further substituted in the indole ring to any extent, whether or not
317317 substituted in the naphthyl ring to any extent, including:
318318 JWH-175;
319319 JWH-184;
320320 JWH-185;
321321 JWH-192;
322322 JWH-194;
323323 JWH-195;
324324 JWH-196;
325325 JWH-197; and
326326 JWH-199;
327327 naphthoylpyrroles structurally derived from
328328 3-(1-naphthoyl)pyrrole with or without [by] substitution at the
329329 nitrogen atom of the pyrrole ring by alkyl, haloalkyl, alkenyl,
330330 cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)
331331 methyl, cyanoalkyl, (N-methylpyrrolidin-2-yl)methyl,
332332 (tetrahydropyran-4-yl)methyl, ((N-methyl)-3-morpholinyl)methyl,
333333 or 2-(4-morpholinyl)ethyl, whether or not further substituted in
334334 the pyrrole ring to any extent, whether or not substituted in the
335335 naphthyl ring to any extent, including:
336336 JWH-030;
337337 JWH-145;
338338 JWH-146;
339339 JWH-147;
340340 JWH-150;
341341 JWH-156;
342342 JWH-243;
343343 JWH-244;
344344 JWH-245;
345345 JWH-246;
346346 JWH-292;
347347 JWH-293;
348348 JWH-307;
349349 JWH-308;
350350 JWH-309;
351351 JWH-346;
352352 JWH-347;
353353 JWH-348;
354354 JWH-363;
355355 JWH-364;
356356 JWH-365;
357357 JWH-366;
358358 JWH-367;
359359 JWH-368;
360360 JWH-369;
361361 JWH-370;
362362 JWH-371;
363363 JWH-372;
364364 JWH-373; and
365365 JWH-392;
366366 naphthylmethylindenes structurally derived from
367367 1-(1-naphthylmethyl)indene with or without [by] substitution at
368368 the 3-position of the indene ring by alkyl, haloalkyl, alkenyl,
369369 cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)
370370 methyl, cyanoalkyl, (N-methylpyrrolidin-2-yl)methyl,
371371 (tetrahydropyran-4-yl)methyl, ((N-methyl)-3-morpholinyl)methyl,
372372 or 2-(4-morpholinyl)ethyl, whether or not further substituted in
373373 the indene ring to any extent, whether or not substituted in the
374374 naphthyl ring to any extent, including:
375375 JWH-171;
376376 JWH-172;
377377 JWH-173; and
378378 JWH-176;
379379 phenylacetylindoles structurally derived from
380380 3-phenylacetylindole with or without [by] substitution at the
381381 nitrogen atom of the indole ring with alkyl, haloalkyl, alkenyl,
382382 cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)
383383 methyl, cyanoalkyl, (N-methylpyrrolidin-2-yl)methyl,
384384 (tetrahydropyran-4-yl)methyl, ((N-methyl)-3-morpholinyl)methyl,
385385 or 2-(4-morpholinyl)ethyl, whether or not further substituted in
386386 the indole ring to any extent, whether or not substituted in the
387387 phenyl ring to any extent, including:
388388 AM-694;
389389 AM-1241;
390390 JWH-167;
391391 JWH-203;
392392 JWH-204;
393393 JWH-205;
394394 JWH-206;
395395 JWH-208;
396396 JWH-237;
397397 JWH-248;
398398 JWH-249;
399399 JWH-250;
400400 JWH-251;
401401 JWH-252;
402402 JWH-253;
403403 JWH-302;
404404 JWH-303;
405405 JWH-305;
406406 JWH-306;
407407 JWH-311;
408408 JWH-312;
409409 JWH-313;
410410 JWH-314; and
411411 JWH-315;
412412 cyclohexylphenols structurally derived from
413413 2-(3-hydroxycyclohexyl)phenol with or without [by] substitution at
414414 the 5-position of the phenolic ring by alkyl, haloalkyl, alkenyl,
415415 cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)
416416 methyl, cyanoalkyl, (N-methylpyrrolidin-2-yl)methyl,
417417 (tetrahydropyran-4-yl)methyl, ((N-methyl)-3-morpholinyl)methyl,
418418 or 2-(4-morpholinyl)ethyl, whether or not substituted in the
419419 cyclohexyl ring to any extent, including:
420420 CP-55,940;
421421 CP-47,497;
422422 analogues of CP-47,497, including VII, V, VIII, I,
423423 II, III, IV, IX, X, XI, XII, XIII, XV, and XVI;
424424 JWH-337;
425425 JWH-344;
426426 JWH-345; and
427427 JWH-405; [and]
428428 benzoylindoles structurally derived from
429429 3-(1-naphthoyl)indole with or without substitution at the nitrogen
430430 atom of the indole ring with alkyl, haloalkyl, alkenyl,
431431 cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)
432432 methyl, cyanoalkyl, (N-methylpyrrolidin-2-yl)methyl,
433433 (tetrahydropyran-4-yl)methyl, ((N-methyl)-3-morpholinyl)methyl,
434434 or 2-(4-morpholinyl)ethyl, whether or not further substituted in
435435 the indole ring to any extent, whether or not substituted in the
436436 phenyl ring to any extent, including:
437437 1-pentyl-3-(4-methoxybenzoyl)indole (RCS-4); and
438438 1-[2-(4-morpholinyl)ethyl]-2-methyl-3-(4-
439439 methoxybenzoyl)indole (Pravadoline or WIN 48,098); and
440440 cannabinol derivatives, except where contained in
441441 marihuana, including tetrahydro derivatives of cannabinol and
442442 3-alkyl homologues of cannabinol or of its tetrahydro derivatives,
443443 such as:
444444 Nabilone;
445445 HU-210;
446446 HU-211; and
447447 WIN-55,212-2.
448448 SECTION 4. Section 481.106, Health and Safety Code, is
449449 amended to read as follows:
450450 Sec. 481.106. CLASSIFICATION OF CONTROLLED SUBSTANCE
451451 ANALOGUE. For the purposes of the prosecution of an offense under
452452 this subchapter involving the manufacture, delivery, or possession
453453 of a controlled substance, Penalty Groups 1, 1-A, [and] 2, and 2-A
454454 include a controlled substance analogue that:
455455 (1) has a chemical structure substantially similar to
456456 the chemical structure of a controlled substance listed in the
457457 applicable penalty group; or
458458 (2) is specifically designed to produce an effect
459459 substantially similar to, or greater than, a controlled substance
460460 listed in the applicable penalty group.
461461 SECTION 5. The change in law made by this Act applies only
462462 to an offense committed on or after the effective date of this Act.
463463 An offense committed before the effective date of this Act is
464464 governed by the law in effect on the date the offense was committed,
465465 and the former law is continued in effect for that purpose. For
466466 purposes of this section, an offense was committed before the
467467 effective date of this Act if any element of the offense occurred
468468 before that date.
469469 SECTION 6. This Act takes effect September 1, 2015.